Erik Solligård
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Erik Solligård has a total of 100 co-authors. Here are the top co-authors by number of shared publications:
- Lise Tuset Gustad
Faculty of Nursing and Health Sciences, Nord University
21 shared publications - Jan Kristian Damås
The Mid-Norway Centre for Sepsis Research, Institute of Circulation and Medical Imaging, Norwegian University of Science and Technology (NTNU), Trondheim, Norway
17 shared publications - Nina Vibeche Skei
Norwegian University of Science and Technology, Central Norway Sepsis Research Centre, Trondheim, Norway
12 shared publications - Bjørn Olav Åsvold
Department of Public Health and Nursing, HUNT Center for Molecular and Clinical Epidemiology, NTNU, Norwegian University of Science and Technology, Trondheim, Norway
11 shared publications - Stian Lydersen
Department of Mental Health, Norwegian University of Science and Technology, Trondheim, Norway
10 shared publications - Anne-Sofie Furberg
Faculty of Health and Social Sciences, Molde University College , 6410 Molde
9 shared publications
Latest Publications
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 1 from Cancer Patients with Sepsis: Prognostic Insights from a Population-Based Cohort Study in Norway
Supplementary Figure 1 shows flowchart of the study population.
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 1 from Cancer Patients with Sepsis: Prognostic Insights from a Population-Based Cohort Study in Norway
Supplementary Figure 1 shows flowchart of the study population.
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Data from Cancer Patients with Sepsis: Prognostic Insights from a Population-Based Cohort Study in Norway
Background:Patients with cancer who had sepsis experience a higher mortality risk than noncancer patients. However, it remains unclear how this risk varies with cancer type and metastasis status, sex, age, and infecting microbe.Methods:This nationwide cohort study included all noncancer patients and those with cancer ≥18 years hospitalized with sepsis in Norway from 2008 to 2021. Cancer status, sepsis, and hospital mortality were identified from the Norwegian Patient Registry (International Classification of Diseases 10th revision codes). Multivariable regression analyses estimated absolute and relative risks (RR) of hospital mortality across subgroups.Results:Of 222,832 hospitalized patients with sepsis, 37,692 (16.9%) had cancer. Hospital mortality was higher in patients with cancer, at 16.9% (males) and 16.2% (females) with nonmetastatic disease, and at 27.1% (males) and 26.2% (females) with metastatic disease. Compared with noncancer patients, adjusted RRs (95% confidence interval) of hospital death were 1.39 (1.34–1.44, males) and 1.63 (1.55–1.71, females) for nonmetastatic cancer and 2.27 (2.18–2.37, males) and 2.75 (2.62–2.89, females) for metastatic cancer. The type of cancer was a key prognostic factor. The association between cancer and mortality was strongest in metastatic patients below 50 years [males 40–49 years: RR, 5.94 (4.43–7.97); females 18–39 years: RR, 8.28 (5.12–13.37)] and in those with gram-negative sepsis.Conclusions:The increased hospital mortality in patients with cancer varied with cancer type and the presence of metastasis. The association between cancer and mortality was strongest in females and young adults, as well as in gram-negative sepsis.Impact:Knowledge of the specific aspects of sepsis in patients with cancer may improve cancer care and guide future research on targeted sepsis therapies.
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessData from Cancer Patients with Sepsis: Prognostic Insights from a Population-Based Cohort Study in Norway
Background:Patients with cancer who had sepsis experience a higher mortality risk than noncancer patients. However, it remains unclear how this risk varies with cancer type and metastasis status, sex, age, and infecting microbe.Methods:This nationwide cohort study included all noncancer patients and those with cancer ≥18 years hospitalized with sepsis in Norway from 2008 to 2021. Cancer status, sepsis, and hospital mortality were identified from the Norwegian Patient Registry (International Classification of Diseases 10th revision codes). Multivariable regression analyses estimated absolute and relative risks (RR) of hospital mortality across subgroups.Results:Of 222,832 hospitalized patients with sepsis, 37,692 (16.9%) had cancer. Hospital mortality was higher in patients with cancer, at 16.9% (males) and 16.2% (females) with nonmetastatic disease, and at 27.1% (males) and 26.2% (females) with metastatic disease. Compared with noncancer patients, adjusted RRs (95% confidence interval) of hospital death were 1.39 (1.34–1.44, males) and 1.63 (1.55–1.71, females) for nonmetastatic cancer and 2.27 (2.18–2.37, males) and 2.75 (2.62–2.89, females) for metastatic cancer. The type of cancer was a key prognostic factor. The association between cancer and mortality was strongest in metastatic patients below 50 years [males 40–49 years: RR, 5.94 (4.43–7.97); females 18–39 years: RR, 8.28 (5.12–13.37)] and in those with gram-negative sepsis.Conclusions:The increased hospital mortality in patients with cancer varied with cancer type and the presence of metastasis. The association between cancer and mortality was strongest in females and young adults, as well as in gram-negative sepsis.Impact:Knowledge of the specific aspects of sepsis in patients with cancer may improve cancer care and guide future research on targeted sepsis therapies.
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S3 from Cancer Patients with Sepsis: Prognostic Insights from a Population-Based Cohort Study in Norway
Supplementary Table S3 shows Distribution of cancer patients with neutropenia and Absolute Risks (AR) (95% CI) and Relative Risks (RR) (95% CI) of hospital mortality by sex and the presence of neutropenia. Norwegian hospitals, 2008 to 2021.
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S3 from Cancer Patients with Sepsis: Prognostic Insights from a Population-Based Cohort Study in Norway
Supplementary Table S3 shows Distribution of cancer patients with neutropenia and Absolute Risks (AR) (95% CI) and Relative Risks (RR) (95% CI) of hospital mortality by sex and the presence of neutropenia. Norwegian hospitals, 2008 to 2021.
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Methods from Cancer Patients with Sepsis: Prognostic Insights from a Population-Based Cohort Study in Norway
Supplementary Methods shows ICD-10 codes used to define sepsis, cancer, and comorbidity.
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Methods from Cancer Patients with Sepsis: Prognostic Insights from a Population-Based Cohort Study in Norway
Supplementary Methods shows ICD-10 codes used to define sepsis, cancer, and comorbidity.
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S1 from Cancer Patients with Sepsis: Prognostic Insights from a Population-Based Cohort Study in Norway
Supplementary Table S1 shows Hospital mortality in cancer patients with sepsis by cancer subtype, Norwegian hospitals 2008 to 2021.
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S1 from Cancer Patients with Sepsis: Prognostic Insights from a Population-Based Cohort Study in Norway
Supplementary Table S1 shows Hospital mortality in cancer patients with sepsis by cancer subtype, Norwegian hospitals 2008 to 2021.
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Tables S2A and S2B from Cancer Patients with Sepsis: Prognostic Insights from a Population-Based Cohort Study in Norway
Supplementary Table S2A shows Hospital mortality in male cancer patients with sepsis by cancer subtype and metastatic status, Norwegian hospitals 2008 to 2021.Supplementary Table S2B shows Hospital mortality in female cancer patients with sepsis by cancer subtype and metastatic status, Norwegian hospitals 2008 to 2021.
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Tables S2A and S2B from Cancer Patients with Sepsis: Prognostic Insights from a Population-Based Cohort Study in Norway
Supplementary Table S2A shows Hospital mortality in male cancer patients with sepsis by cancer subtype and metastatic status, Norwegian hospitals 2008 to 2021.Supplementary Table S2B shows Hospital mortality in female cancer patients with sepsis by cancer subtype and metastatic status, Norwegian hospitals 2008 to 2021.
- Open Access
- 22 May 2026
- Published by Springer Nature in Infection
Evaluation of ambulance blood cultures in patients with suspected sepsis. A rural prospective cohort study
Purpose: To describe the epidemiology of blood cultures (BCs) drawn from patients with suspected sepsis by a rural ambulance service. Methods: Patients were included if they had clinically suspected sepsis and at least one BC was drawn. Variables associated with positive BCs were identified with logistic regression, culture results before and after ambulance antimicrobial therapy were compared and the susceptibility to empirical antimicrobial therapy in bacterial isolates was determined. Results: Among 392 included patients, sepsis severity score were higher when BCs were positive than negative, but there was no significant difference in 30-day all-cause mortality between BC negative and positive patients. In 47 patients ambulance blood cultures were positive (47/347 (13,5%)). Fever (OR 1.54, 95% CI 1.11–2.15) was associated with higher odds of positive cultures, while lower respiratory tract infection was associated with lower odds of positive cultures (OR 0.10, 95% CI 0.04–0.30). In 205 patients who had both ambulance and hospital BCs drawn and received ambulance antimicrobial therapy, only the ambulance BCs were positive in 16 patients, whereas in 4 patients only hospital cultures were positive. Bacterial isolates from positive BCs were susceptible to the empirical antimicrobial regimen in 80% of cases. Conclusion: Positive ambulance BCs were associated with higher sepsis severity, and ambulance cultures were most useful in febrile patients with a suspected focus of infection other than the lower airways. Repeated BCs after hospital admission added only limited diagnostic value if an adequate ambulance BC had already been drawn.
- 22 May 2026
- Published by Springer Nature in Infection
Open AccessEvaluation of ambulance blood cultures in patients with suspected sepsis. A rural prospective cohort study
Purpose: To describe the epidemiology of blood cultures (BCs) drawn from patients with suspected sepsis by a rural ambulance service. Methods: Patients were included if they had clinically suspected sepsis and at least one BC was drawn. Variables associated with positive BCs were identified with logistic regression, culture results before and after ambulance antimicrobial therapy were compared and the susceptibility to empirical antimicrobial therapy in bacterial isolates was determined. Results: Among 392 included patients, sepsis severity score were higher when BCs were positive than negative, but there was no significant difference in 30-day all-cause mortality between BC negative and positive patients. In 47 patients ambulance blood cultures were positive (47/347 (13,5%)). Fever (OR 1.54, 95% CI 1.11–2.15) was associated with higher odds of positive cultures, while lower respiratory tract infection was associated with lower odds of positive cultures (OR 0.10, 95% CI 0.04–0.30). In 205 patients who had both ambulance and hospital BCs drawn and received ambulance antimicrobial therapy, only the ambulance BCs were positive in 16 patients, whereas in 4 patients only hospital cultures were positive. Bacterial isolates from positive BCs were susceptible to the empirical antimicrobial regimen in 80% of cases. Conclusion: Positive ambulance BCs were associated with higher sepsis severity, and ambulance cultures were most useful in febrile patients with a suspected focus of infection other than the lower airways. Repeated BCs after hospital admission added only limited diagnostic value if an adequate ambulance BC had already been drawn.
- 6 May 2026
- Published by BMJ in Emergency Medicine Journal
Prehospital prediction of clinical course in patients with suspected sepsis: a prospective cohort study
Background: Early prediction of the clinical course may aid clinical decisions for patients with suspected sepsis. We examined how variables observed by ambulance personnel predicted the clinical course in patients with suspected sepsis. Methods: We prospectively collected prehospital data from patients with suspected sepsis in the ambulance service and supplemented the data with in-hospital findings. Prehospital data were used to calculate outputs of quick Sequential Organ Failure Assessment (qSOFA) and National Early Warning Score-2 (NEWS2). Outcomes were (1) sepsis severity after hospital admission, measured by Sequential Organ Failure Assessment (SOFA) score; (2) development of septic shock, defined by need for intravenous fluid resuscitation and pressors; and (3) 30-day all-cause mortality. Factors that predicted the three outcomes were identified with regression analysis. We performed receiver operating characteristic curve analysis to find the discriminatory abilities of prehospital scores. Results: We included 398 patients with a median age of 76 years and a 30-day all-cause mortality of 10.1%. Oxygen saturation, systolic blood pressure and qSOFA were associated with sepsis severity and septic shock; Glasgow Coma Score and male sex with sepsis severity and mortality; age with sepsis severity; ashen or marbled skin and focus of infection with septic shock; cyanosis, nursing home resident and comorbidity with mortality. No variable predicted all three outcomes. Area under the curve (AUC) for septic shock was higher for qSOFA than for NEWS2 (p=0.033). AUC for septic shock was higher for males than for females if NEWS2 score was used (p=0.049), indicating that NEWS2 is better at predicting shock among males compared with females. Conclusions: While there may be a role for the use of prehospital scoring systems in patients who are critically ill on presentation, established clinical decision aids must be used with caution and predictive information is lost if the tools are applied alone.
- 6 May 2026
- Published by BMJ in Emergency Medicine Journal
Prehospital prediction of clinical course in patients with suspected sepsis: a prospective cohort study
Background: Early prediction of the clinical course may aid clinical decisions for patients with suspected sepsis. We examined how variables observed by ambulance personnel predicted the clinical course in patients with suspected sepsis. Methods: We prospectively collected prehospital data from patients with suspected sepsis in the ambulance service and supplemented the data with in-hospital findings. Prehospital data were used to calculate outputs of quick Sequential Organ Failure Assessment (qSOFA) and National Early Warning Score-2 (NEWS2). Outcomes were (1) sepsis severity after hospital admission, measured by Sequential Organ Failure Assessment (SOFA) score; (2) development of septic shock, defined by need for intravenous fluid resuscitation and pressors; and (3) 30-day all-cause mortality. Factors that predicted the three outcomes were identified with regression analysis. We performed receiver operating characteristic curve analysis to find the discriminatory abilities of prehospital scores. Results: We included 398 patients with a median age of 76 years and a 30-day all-cause mortality of 10.1%. Oxygen saturation, systolic blood pressure and qSOFA were associated with sepsis severity and septic shock; Glasgow Coma Score and male sex with sepsis severity and mortality; age with sepsis severity; ashen or marbled skin and focus of infection with septic shock; cyanosis, nursing home resident and comorbidity with mortality. No variable predicted all three outcomes. Area under the curve (AUC) for septic shock was higher for qSOFA than for NEWS2 (p=0.033). AUC for septic shock was higher for males than for females if NEWS2 score was used (p=0.049), indicating that NEWS2 is better at predicting shock among males compared with females. Conclusions: While there may be a role for the use of prehospital scoring systems in patients who are critically ill on presentation, established clinical decision aids must be used with caution and predictive information is lost if the tools are applied alone.
- Open Access
- 22 April 2026
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Long-term trends in incidence and mortality in Staphylococcus aureus bacteraemia; a retrospective population-based study from Central Norway 1996–2022
Objectives: This study aims to examine changes in incidence and mortality in Staphylococcus aureus bacteraemia (SAB) over time and between sexes, describe clinical characteristics and asses their associations with 30-day mortality. Methods: We included 837 first-time SAB episodes from 1996 to 2022 in patients aged 18 years or older recorded in the Nord-Trøndelag Hospital Trust Sepsis Registry. Logistic regression was used to investigate time trends and associations with mortality. The study period was divided into early- (1996–2004), mid- (2005–2013) and late- (2014–2022) periods, and results are reported for each period and overall. Results: The incidence of SAB increased from 20.0 to 40.3 per 100 000 person years from the early- to the late periods, with males accounting for 522 (62.4%) of all cases. Mortality decreased from 22.6% to 19.0% in males and 29.2% to 20.0% in females. Higher age, malignancy, congestive heart failure, pulmonary infection focus, and unknown focus were associated with increased 30-days mortality. Conclusion: The incidence rate of SAB increased significantly from 1996 to 2022, with a consistently higher rate in males compared to females. While the highest mortality rate was observed in females in the earliest period, the mortality rate was similar between the sexes in the last period. The decline in mortality occurred despite an ageing patient population and a stable burden of comorbidities. With the exception of age, none of the variables associated with increased or decreased mortality changed significantly over time. Clinical trial number: Not applicable.
- 22 April 2026
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Open AccessLong-term trends in incidence and mortality in Staphylococcus aureus bacteraemia; a retrospective population-based study from Central Norway 1996–2022
Objectives: This study aims to examine changes in incidence and mortality in Staphylococcus aureus bacteraemia (SAB) over time and between sexes, describe clinical characteristics and asses their associations with 30-day mortality. Methods: We included 837 first-time SAB episodes from 1996 to 2022 in patients aged 18 years or older recorded in the Nord-Trøndelag Hospital Trust Sepsis Registry. Logistic regression was used to investigate time trends and associations with mortality. The study period was divided into early- (1996–2004), mid- (2005–2013) and late- (2014–2022) periods, and results are reported for each period and overall. Results: The incidence of SAB increased from 20.0 to 40.3 per 100 000 person years from the early- to the late periods, with males accounting for 522 (62.4%) of all cases. Mortality decreased from 22.6% to 19.0% in males and 29.2% to 20.0% in females. Higher age, malignancy, congestive heart failure, pulmonary infection focus, and unknown focus were associated with increased 30-days mortality. Conclusion: The incidence rate of SAB increased significantly from 1996 to 2022, with a consistently higher rate in males compared to females. While the highest mortality rate was observed in females in the earliest period, the mortality rate was similar between the sexes in the last period. The decline in mortality occurred despite an ageing patient population and a stable burden of comorbidities. With the exception of age, none of the variables associated with increased or decreased mortality changed significantly over time. Clinical trial number: Not applicable.
- Open Access
- 4 December 2025
- Published by Springer Nature in Research Square
Long-term trends in incidence and mortality in Staphylococcus aureus bacteraemia; a retrospective population-based study from Central Norway 1996-2022
Objectives This study aims to examine changes in incidence and mortality in Staphylococcus aureus bacteraemia (SAB) over time and between sexes, describe clinical characteristics and assess their associations with 30-day mortality. Methods We included 837 first-time SAB episodes from 1996 through 2022 in patients aged 18 years or older recorded in the Nord-Trøndelag Hospital Trust Sepsis Registry. Logistic regression was used to investigate time trends and associations with mortality. The study period was divided into early- (1996–2004), mid- (2005–2013) and late- (2014–2022) periods, and results are reported for each period and overall. Results The incidence of SAB increased from 20.0 to 40.3 per 100 000 person years from the early- to the late periods, with males accounting for 522 (62.4%) of all cases. Mortality decreased from 22.6% to 19.0% in males and 29.2% to 20.0% in females. Higher age, malignancy, congestive heart failure, pulmonary infection focus, and unknown focus were associated with increased 30-days mortality. Conclusion The incidence rate of SAB increased significantly from 1996 to 2022, with a consistently higher rate in males compared to females. While the highest mortality rate was observed in females in the earliest period, the mortality rate declined more in females than males, resulting in similar rates between the sexes in the last period. This decline occurred despite an ageing patient population and a stable burden of comorbidities. With the exception of age, none of the variables associated with increased or decreased mortality changed significantly over time.
- 4 December 2025
- Published by Springer Nature in Research Square
Open AccessLong-term trends in incidence and mortality in Staphylococcus aureus bacteraemia; a retrospective population-based study from Central Norway 1996-2022
Objectives This study aims to examine changes in incidence and mortality in Staphylococcus aureus bacteraemia (SAB) over time and between sexes, describe clinical characteristics and assess their associations with 30-day mortality. Methods We included 837 first-time SAB episodes from 1996 through 2022 in patients aged 18 years or older recorded in the Nord-Trøndelag Hospital Trust Sepsis Registry. Logistic regression was used to investigate time trends and associations with mortality. The study period was divided into early- (1996–2004), mid- (2005–2013) and late- (2014–2022) periods, and results are reported for each period and overall. Results The incidence of SAB increased from 20.0 to 40.3 per 100 000 person years from the early- to the late periods, with males accounting for 522 (62.4%) of all cases. Mortality decreased from 22.6% to 19.0% in males and 29.2% to 20.0% in females. Higher age, malignancy, congestive heart failure, pulmonary infection focus, and unknown focus were associated with increased 30-days mortality. Conclusion The incidence rate of SAB increased significantly from 1996 to 2022, with a consistently higher rate in males compared to females. While the highest mortality rate was observed in females in the earliest period, the mortality rate declined more in females than males, resulting in similar rates between the sexes in the last period. This decline occurred despite an ageing patient population and a stable burden of comorbidities. With the exception of age, none of the variables associated with increased or decreased mortality changed significantly over time.